• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

调节性 T 细胞诱导抑制性免疫微环境并促进肝内胆管癌的淋巴结转移。

Regulatory T cells induce a suppressive immune milieu and promote lymph node metastasis in intrahepatic cholangiocarcinoma.

机构信息

Department of Gastroenterological Surgery and Surgical Oncology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan.

Department of Diagnostic Pathology, Okayama University Hospital, Okayama, Japan.

出版信息

Br J Cancer. 2022 Sep;127(4):757-765. doi: 10.1038/s41416-022-01838-y. Epub 2022 May 21.

DOI:10.1038/s41416-022-01838-y
PMID:35597869
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9381563/
Abstract

BACKGROUND

Emerging evidence indicates that immunogenicity plays an important role in intrahepatic cholangiocarcinoma (ICC). Herein, we systematically evaluated the clinical relevance of immunogenicity in ICC.

METHODS

Highly immunogenic ICCs identified in the public dataset and the Cancer Immunome Atlas (TCIA) were assessed to determine the prognostic impact of immunogenicity in ICC and key components after curative resection. We also investigated the clinical relevance of the immune milieu in ICC.

RESULTS

Using the Gene Expression Omnibus dataset 89749 and TCIA, we identified CD8/forkhead box P3 (FoxP3) tumour-infiltrating lymphocytes (TILs), T-cell immunoglobulin and mucin domain 3 (TIM-3) and human leukocyte antigen-A (HLA-A) in highly immunogenic ICCs. Immunohistochemical analysis of the in-house cohort showed that intratumoral FoxP3 TILs correlated with CD8 TILs (P = 0.045, Fisher's exact test) and that high FoxP3/CD8 ratio (FCR) was an important marker for poor survival (P < 0.001, log-rank test). Furthermore, the FCR was higher in tumour-free lymph nodes in ICCs with lymph node metastases than in those without lymph node metastases (P = 0.003, Mann-Whitney U test).

CONCLUSIONS

FCR should be considered an important biomarker that represents the immune environment of ICC based on its potentially important role in tumour progression, especially lymph node metastasis.

摘要

背景

新出现的证据表明,免疫原性在肝内胆管癌(ICC)中起着重要作用。在此,我们系统地评估了 ICC 中免疫原性的临床相关性。

方法

在公共数据集和癌症免疫图谱(TCIA)中评估高免疫原性 ICC,以确定 ICC 及根治性切除后关键成分的免疫原性的预后影响。我们还研究了 ICC 中免疫微环境的临床相关性。

结果

使用基因表达综合数据集 89749 和 TCIA,我们在高免疫原性 ICC 中鉴定了 CD8/叉头框 P3(FoxP3)肿瘤浸润淋巴细胞(TILs)、T 细胞免疫球蛋白和粘蛋白结构域 3(TIM-3)和人类白细胞抗原-A(HLA-A)。对内部队列的免疫组织化学分析表明,肿瘤内 FoxP3 TILs 与 CD8 TILs 相关(P=0.045,Fisher 确切检验),高 FoxP3/CD8 比值(FCR)是生存不良的重要标志物(P<0.001,对数秩检验)。此外,在有淋巴结转移的 ICC 中,无淋巴结转移的肿瘤内 FCR 高于肿瘤内 FCR(P=0.003,Mann-Whitney U 检验)。

结论

FCR 应被视为一种重要的生物标志物,代表 ICC 的免疫环境,基于其在肿瘤进展,特别是淋巴结转移中的潜在重要作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f6f7/9381563/22d036ed466f/41416_2022_1838_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f6f7/9381563/79f03f8b5826/41416_2022_1838_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f6f7/9381563/bb5f951d0b75/41416_2022_1838_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f6f7/9381563/325eacd4912b/41416_2022_1838_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f6f7/9381563/22d036ed466f/41416_2022_1838_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f6f7/9381563/79f03f8b5826/41416_2022_1838_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f6f7/9381563/bb5f951d0b75/41416_2022_1838_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f6f7/9381563/325eacd4912b/41416_2022_1838_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f6f7/9381563/22d036ed466f/41416_2022_1838_Fig4_HTML.jpg

相似文献

1
Regulatory T cells induce a suppressive immune milieu and promote lymph node metastasis in intrahepatic cholangiocarcinoma.调节性 T 细胞诱导抑制性免疫微环境并促进肝内胆管癌的淋巴结转移。
Br J Cancer. 2022 Sep;127(4):757-765. doi: 10.1038/s41416-022-01838-y. Epub 2022 May 21.
2
CTLA-4 Synergizes With PD1/PD-L1 in the Inhibitory Tumor Microenvironment of Intrahepatic Cholangiocarcinoma.CTLA-4 与 PD1/PD-L1 在肝内胆管癌抑制性肿瘤微环境中协同作用。
Front Immunol. 2021 Aug 30;12:705378. doi: 10.3389/fimmu.2021.705378. eCollection 2021.
3
Prognostic impact of tumor microvessels in intrahepatic cholangiocarcinoma: association with tumor-infiltrating lymphocytes.肝内胆管癌中肿瘤微血管对预后的影响:与肿瘤浸润淋巴细胞的关系。
Mod Pathol. 2021 Apr;34(4):798-807. doi: 10.1038/s41379-020-00702-9. Epub 2020 Oct 19.
4
Preoperative HALP score is a prognostic factor for intrahepatic cholangiocarcinoma patients undergoing curative hepatic resection: association with sarcopenia and immune microenvironment.术前 HALP 评分是接受根治性肝切除术的肝内胆管癌患者的预后因素:与肌肉减少症和免疫微环境相关。
Int J Clin Oncol. 2023 Aug;28(8):1082-1091. doi: 10.1007/s10147-023-02358-2. Epub 2023 May 29.
5
Integrative analyses identify CD73 as a prognostic biomarker and immunotherapeutic target in intrahepatic cholangiocarcinoma.整合分析确定 CD73 为肝内胆管癌的预后生物标志物和免疫治疗靶点。
World J Surg Oncol. 2023 Mar 10;21(1):90. doi: 10.1186/s12957-023-02970-6.
6
Cancer-associated fibroblast senescence and its relation with tumour-infiltrating lymphocytes and PD-L1 expressions in intrahepatic cholangiocarcinoma.癌相关成纤维细胞衰老及其与肝内胆管癌肿瘤浸润淋巴细胞和 PD-L1 表达的关系。
Br J Cancer. 2022 Feb;126(2):219-227. doi: 10.1038/s41416-021-01569-6. Epub 2021 Oct 6.
7
Identification of Homer1 as a potential prognostic marker for intrahepatic cholangiocarcinoma.鉴定Homer1作为肝内胆管癌的潜在预后标志物。
Asian Pac J Cancer Prev. 2014;15(7):3299-304. doi: 10.7314/apjcp.2014.15.7.3299.
8
Mutated EPHA2 is a target for combating lymphatic metastasis in intrahepatic cholangiocarcinoma.突变型 EphA2 是治疗肝内胆管癌淋巴转移的靶点。
Int J Cancer. 2019 May 15;144(10):2440-2452. doi: 10.1002/ijc.31979. Epub 2019 Jan 11.
9
IgG4 expression and IgG4/IgG ratio in the tumour invasion front predict long-term outcomes for patients with intrahepatic cholangiocarcinoma.肿瘤浸润前沿的IgG4表达及IgG4/IgG比值可预测肝内胆管癌患者的长期预后。
Pathology. 2023 Jun;55(4):508-513. doi: 10.1016/j.pathol.2022.11.007. Epub 2023 Feb 3.
10
Intrahepatic cholangiocarcinoma: prognostic factors after surgical resection.肝内胆管癌:手术切除后的预后因素
World J Surg. 2009 Jun;33(6):1247-54. doi: 10.1007/s00268-009-9970-0.

引用本文的文献

1
Application and mechanism of anticancer peptides in organoid models of intrahepatic cholangiocarcinoma.抗癌肽在肝内胆管癌类器官模型中的应用及机制
Sci Rep. 2025 Jul 2;15(1):22870. doi: 10.1038/s41598-025-06127-1.
2
Anti-vascular endothelial growth factor treatment potentiates immune checkpoint blockade through a BAFF- and IL-12-dependent reprogramming of the TME.抗血管内皮生长因子治疗通过对肿瘤微环境进行BAFF和IL-12依赖性重编程来增强免疫检查点阻断作用。
Immunity. 2025 Apr 8;58(4):926-945.e10. doi: 10.1016/j.immuni.2025.02.017. Epub 2025 Mar 14.
3
Research progress of T cells in cholangiocarcinoma.

本文引用的文献

1
CD8 cytotoxic and FoxP3 regulatory T lymphocytes serve as prognostic factors in breast cancer.CD8细胞毒性T淋巴细胞和FoxP3调节性T淋巴细胞是乳腺癌的预后因素。
Am J Transl Res. 2019 Aug 15;11(8):5039-5053. eCollection 2019.
胆管癌中T细胞的研究进展
Front Immunol. 2025 Feb 25;16:1453344. doi: 10.3389/fimmu.2025.1453344. eCollection 2025.
4
Hepatic Stellate Cells Functional Heterogeneity in Liver Cancer.肝癌中肝星状细胞的功能异质性
Semin Liver Dis. 2025 Mar;45(1):33-51. doi: 10.1055/a-2551-0724. Epub 2025 Mar 5.
5
The Immune Landscape and Its Potential for Immunotherapy in Advanced Biliary Tract Cancer.晚期胆管癌的免疫格局及其免疫治疗潜力
Curr Oncol. 2024 Dec 31;32(1):24. doi: 10.3390/curroncol32010024.
6
Infiltrating T lymphocytes and tumor microenvironment within cholangiocarcinoma: immune heterogeneity, intercellular communication, immune checkpoints.胆管癌中的浸润性T淋巴细胞与肿瘤微环境:免疫异质性、细胞间通讯、免疫检查点
Front Immunol. 2025 Jan 8;15:1482291. doi: 10.3389/fimmu.2024.1482291. eCollection 2024.
7
Genetic, Epigenetic, and Microenvironmental Drivers of Cholangiocarcinoma.胆管癌的遗传、表观遗传和微环境驱动因素
Am J Pathol. 2025 Mar;195(3):362-377. doi: 10.1016/j.ajpath.2024.10.013. Epub 2024 Nov 10.
8
Stroma-tology: Predicting recurrence in cholangiocarcinoma: Editorial on "Development and validation of a stromal-immune signature to predict prognosis in intrahepatic cholangiocarcinoma".间质学:预测胆管癌复发:关于“用于预测肝内胆管癌预后的间质-免疫特征的开发与验证”的社论
Clin Mol Hepatol. 2025 Jan;31(1):323-326. doi: 10.3350/cmh.2024.0932. Epub 2024 Oct 29.
9
An inflammatory liquid fingerprint predicting tumor recurrence after liver transplantation for hepatocellular carcinoma.一种预测肝细胞癌肝移植术后肿瘤复发的炎性液体指纹图谱。
MedComm (2020). 2024 Aug 26;5(9):e678. doi: 10.1002/mco2.678. eCollection 2024 Sep.
10
Strategies for treating the cold tumors of cholangiocarcinoma: core concepts and future directions.治疗胆管癌冷肿瘤的策略:核心概念和未来方向。
Clin Exp Med. 2024 Aug 14;24(1):193. doi: 10.1007/s10238-024-01460-7.